Core Viewpoint - Xinhua Medical (600587) is focusing on its core businesses in medical devices and pharmaceutical equipment, while maintaining a significant stake in Huajian Medical, which is undergoing strategic transformation in the medical innovation sector [2][3]. Group 1: Company Performance - As of August 18, 2025, Xinhua Medical's stock closed at 17.3 yuan, down 1.54%, with a turnover rate of 3.43%, a trading volume of 207,200 shares, and a transaction value of 361 million yuan [1]. - On August 11, Huajian Medical's market capitalization reached 15 billion HKD, with Xinhua Medical's stake valued at 4.1 billion HKD [3]. Group 2: Stake in Huajian Medical - Xinhua Medical holds 443.7 million shares of Huajian Medical, representing a 27.29% ownership stake, which is accounted for using the equity method [2][3]. - The net profit fluctuations of Huajian Medical will directly impact Xinhua Medical's investment income [2][3]. Group 3: Strategic Developments - Huajian Medical is pursuing a strategic transformation involving the development of a medical innovation drug asset ecosystem and associated stablecoin, which may provide new growth opportunities [2][3]. - Xinhua Medical is committed to monitoring the risks and opportunities in the industry related to Huajian Medical's developments [2][3]. Group 4: Market Activity - On August 18, 2025, the net outflow of main funds from Xinhua Medical was 75.5 million yuan, accounting for 20.89% of the total transaction value [4]. - Retail investors contributed a net inflow of 39.7 million yuan, representing 10.98% of the total transaction value [4].

转自：智通财经 【新华医疗：华检医疗推进医疗创新药RWA交易所生态】智通财经8月18日电，新华医疗在互动平台表 示，华检医疗推进的医疗创新药RWA交易所生态及配套稳定币体系，为业务拓展提供了新的发展思 路，公司未来将持续关注华检医疗所处行业的风险与机遇。 ...

Group 1 - The core viewpoint of the article highlights that Xinhua Medical (600587.SH) is exploring new development ideas through the medical innovation drug RWA exchange ecosystem and its associated stablecoin system promoted by Huajian Medical [1] - The company will continue to pay attention to the risks and opportunities in the industry where Huajian Medical operates [1]